Citation Impact
Citing Papers
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Assays of different aspects of haemostasis – what do they measure?
2015 StandoutNobel
Early and individualized goal-directed therapy for trauma-induced coagulopathy
2012
Cerebral visual impairment in children
2001 Standout
Albumin-induced coagulopathy is less severe and more effectively reversed with fibrinogen concentrate than is synthetic colloid-induced coagulopathy
2013
Haemostatic materials for wound healing applications
2021 Standout
Prophylactic plasma and platelet transfusion in the critically Ill patient: just useless and expensive or even harmful?
2015
Early cryoprecipitate for major haemorrhage in trauma: a randomised controlled feasibility trial
2015
Periventricular Leukomalacia
2000
Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding
2017
Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial
2015
Factor XIII Deficiency and Thrombocytopenia Are Frequent Modulators of Postoperative Clot Firmness in a Surgical Intensive Care Unit
2017
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Idarucizumab for Dabigatran Reversal
2015 Standout
Effects of fibrinogen and platelet supplementation on clot formation and platelet aggregation in blood samples from cardiac surgery patients
2014
Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-centre, parallel-group, open-label, randomised trial
2017
Benefits and harms of 4-factor prothrombin complex concentrate for reversal of vitamin K antagonist associated bleeding: a systematic review and meta-analysis
2017
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
How I use fibrinogen replacement therapy in acquired bleeding
2014
DNA tags help the hunt for drugs
2016 Nature
Choosing Wisely for apheresis
2018
Assessing the Efficacy of Prothrombin Complex Concentrate in Multiply Injured Patients With High-Energy Pelvic and Extremity Fractures
2016
COVID-19 and its implications for thrombosis and anticoagulation
2020 Standout
Comparing efficacy and safety of fibrinogen concentrate to cryoprecipitate in bleeding patients: a systematic review
2016
Efficacy and Safety of a 4-Factor Prothrombin Complex Concentrate in Patients on Vitamin K Antagonists Presenting With Major Bleeding
2013
Physical unclonable functions generated through chemical methods for anti-counterfeiting
2017 Standout
Works of Lucy Yang being referenced
Is fresh‐frozen plasma clinically effective? An update of a systematic review of randomized controlled trials (CME)
2012
Assessment of thrombin generation measured before and after cardiopulmonary bypass surgery and its association with postoperative bleeding
2010
Postoperative fibrinogen level is associated with postoperative bleeding following cardiothoracic surgery and the effect of fibrinogen replacement therapy remains uncertain
2013
Reappraisal of Occlusion Therapy for Severe Structural Abnormalities of the Optic Disc and Macula
1995
Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor
2015
Cryoprecipitate: an outmoded treatment?
2012